Literature DB >> 19146391

Biochemical characterization of recombinant hepatitis C virus nonstructural protein 4B: evidence for ATP/GTP hydrolysis and adenylate kinase activity.

Aaron A Thompson1, Aihua Zou, Jiangli Yan, Rohit Duggal, Weidong Hao, David Molina, Ciarán N Cronin, Peter A Wells.   

Abstract

While nonstructural protein 4B (NS4B) from hepatitis C virus (HCV) is absolutely required for viral propagation, a full understanding of the enzymatic properties of this protein is lacking. Previous studies suggest that NS4B is located at the endoplasmic reticulum and that the protein structure consists of four central transmembrane domains with the N- and C-termini located in the cytoplasm of the host cell. To characterize the enzymatic activity of NS4B, the full-length protein with a C-terminal His tag was expressed in Sf9 insect cells and stabilized with nonionic detergents during purification. Chemical cross-linking experiments using GTP-gamma-azidoanilide and ATP-gamma-azidoanilide and equilibrium binding analyses with GTPgammaS and ATPgammaS show that both GTP and ATP are bound by NS4B, with ATP displaying a higher affinity. Analyses of enzymatic reactions catalyzed by NS4B indicate that the terminal phosphate groups of ATP, GTP, and GDP are removed to produce ADP, GDP, and GMP, respectively. The k(cat) for hydrolysis of GTP by purified NS4B compared favorably with the k(cat) for hydrolysis of GTP by Ras-p21 in the absence of GTPase activating proteins (GAPs). In addition to the hydrolysis of NTP and NDP substrates, adenylate kinase activity was detected in purified preparations of NS4B with the reverse reaction 2ADP --> ATP + ADP, yielding a larger k(cat) compared to that of the forward reaction ATP + AMP --> 2ADP. These studies suggest that HCV NS4B possesses both adenylate kinase activity and nucleotide hydrolase activity. Mutation of amino acids in the Walker A and B motifs of NS4B resulted in decreased affinity for both GTPgammaS and ATPgammaS as well as decreased ATP hydrolysis and AK activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19146391     DOI: 10.1021/bi801747p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Analysis of Immumoreactivity of Heterologously Expressed Non-structural Protein 4B (NS4B) from Hepatitis C Virus (HCV) Genotype 1a.

Authors:  Amir Savardashtaki; Zohreh Sharifi; Sepideh Hamzehlou; Mohammad M Farajollahi
Journal:  Iran J Biotechnol       Date:  2015-12       Impact factor: 1.671

2.  Encoded library technology screening of hepatitis C virus NS4B yields a small-molecule compound series with in vitro replicon activity.

Authors:  Christopher Arico-Muendel; Zhengrong Zhu; Hamilton Dickson; Derek Parks; Jesse Keicher; Jianghe Deng; Leah Aquilani; Frank Coppo; Todd Graybill; Kenneth Lind; Andrew Peat; Michael Thomson
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

3.  Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein.

Authors:  Zhengxian Gu; Jason D Graci; Frederick C Lahser; Jamie J Breslin; Stephen P Jung; James H Crona; Patricia McMonagle; Ellen Xia; Shaotang Liu; Gary Karp; Jin Zhu; Song Huang; Amin Nomeir; Marla Weetall; Neil G Almstead; Stuart W Peltz; Xiao Tong; Robert Ralston; Joseph M Colacino
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

4.  Charged residues in hepatitis C virus NS4B are critical for multiple NS4B functions in RNA replication.

Authors:  Keril J Blight
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

5.  Conserved GXXXG- and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replication.

Authors:  Qingxia Han; Jason Aligo; David Manna; Kerry Belton; Sree V Chintapalli; Yoojin Hong; Randen L Patterson; Damian B van Rossum; Kouacou V Konan
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

Review 6.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

7.  Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein.

Authors:  Jeffrey J Pouliot; Michael Thomson; Mi Xie; Joseph Horton; John Johnson; David Krull; Amanda Mathis; Yoshio Morikawa; Derek Parks; Richard Peterson; Takashi Shimada; Elizabeth Thomas; Jessica Vamathevan; Stephanie Van Horn; Zhiping Xiong; Robert Hamatake; Andrew J Peat
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

8.  An amphipathic alpha-helix at the C terminus of hepatitis C virus nonstructural protein 4B mediates membrane association.

Authors:  Jérôme Gouttenoire; Roland Montserret; Audrey Kennel; François Penin; Darius Moradpour
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

9.  Mutations in classical swine fever virus NS4B affect virulence in swine.

Authors:  I Fernandez-Sainz; D P Gladue; L G Holinka; V O'Donnell; I Gudmundsdottir; M V Prarat; J R Patch; W T Golde; Z Lu; J Zhu; C Carrillo; G R Risatti; M V Borca
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

10.  NS4A regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural protein NS4A from West Nile virus.

Authors:  Sergey A Shiryaev; Andrei V Chernov; Alexander E Aleshin; Tatiana N Shiryaeva; Alex Y Strongin
Journal:  J Gen Virol       Date:  2009-05-27       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.